Accumulating evidences indicate that p120 catenin, a member of the E-cadherin (E-CD)/catenin adhesion complex, plays a role in tumor invasion. To establish the expression pattern of p120 in breast cancer, we analysed 326 breast tissue biopsies by tissue microarray. Most of the lobular tumors (88%) showed exclusive cytoplasmic localization, and 6% of them also had p120 nuclear staining. Cytoplasmic p120 strongly associated with complete loss of E-CD and b-catenin not only in lobular carcinoma and its metastases but also in atypical lobular hyperplasias. In the latter, loss of heterozygosity of E-CD gene was also observed. Complete loss of E-CD and cytoplasmic and nuclear p120 staining was also observed in primary lobular cancer cell cultures generated by us. In ductal tumors, by contrast, reduction of p120 and E-CD in membrane was very common (57 and 53%, respectively), whereas cytoplasmic p120 staining was rarely seen. This simultaneous reduction of membranous E-CD and p120 was not associated with increased Src kinase activity. To demonstrate that cytoplasmic p120 localization was a consequence of the absence of E-CD, the endogenous E-CD was re-expressed in MDA-231 cells by 5-Aza-2 0 -deoxycytidine (5Aza) treatment. After treatment, p120 shifted from the cytoplasm to the membrane, where it colocalized with endogenous E-CD. Additionally, suppressing E-CD expression in Madin-Darby canine kidney cells by stable transfection of the transcriptional repressors Snail, E47 or Slug, provokes p120 cytoplasmic localization and p120 isoform switching. In conclusion, abnormal cytoplasmic and nuclear localization of p120, which are mediated by the absence of E-CD, characteristically occur in the early stages of lobular breast cancer and are maintained during tumor progression to metastasis. Consequently, p120 may be an important mediator of the oncogenic effects derived from E-CD inactivation, including enhanced motility and invasion, in lobular breast cancer.
Introduction
Dysfunction of the cadherin-catenin adhesion complex is intimately related to malignancy. Several lines of evidence have demonstrated that defects in various components of the E-cadherin (E-CD) complex result in decreased cell-cell adhesiveness and increased tumor metastasis (reviewed in Beavon, 2000) . E-CD, the major cell-cell adhesion protein in epithelial tissues, is frequently downregulated in epithelial cancers, and is widely acknowledged to be both a tumor and metastasis suppressor (Christofori and Semb, 1999) . In breast cancer, most of the invasive lobular carcinoma (ILC) and lobular carcinoma in situ (LCIS) completely lack E-CD expression, but complete loss of E-CD protein does not occur in ductal tumors (Gamallo et al., 1993) . In lobular tumors, E-CD loss is attributable to many defects in E-CD gene (CDH1), including inactivating mutations, loss of heterozygosity (LOH), and promoter hypermethylation (Droufakou et al., 2001; Sarrio´et al., 2003) . The cytoplasmic domain of E-CD interacts with a group of proteins called catenins, which are characterized by a central armadillo repeat domain. b-and gcatenin bind in a mutually exclusive manner to the catenin-binding domain of E-CD and mediate the binding of the complex to the actin cytoskeleton through a-catenin (Nagafuchi, 2001 ). In addition, band g-catenin bind to APC and are able to translocate into the nucleus, thus participating in the Wnt signaling pathway (Conacci-Sorrell et al., 2002) . p120ctn (p120), which was initially described as a prominent Src substrate (Reynolds et al., 1992) , also belongs to the catenin family and is closely homologous with b-and gcatenin . However, p120 differs from the other catenins in a number of respects. Unlike b-or g-catenin, p120 does not interact with a-catenin or APC, but binds to the juxtamembrane domain of E-CD (Daniel and Reynolds, 1995) . However, the role of p120 is currently controversial since evidence suggests that p120 can both positively and negatively regulate adhesive activity . One reason for this apparent contradiction may lie in the large number of p120 isoforms expressed in different cells and tissues (Mo and Reynolds, 1996; Keiserbilck et al., 1998) . These isoforms, which arise as a result of alternative splicing events, may have tissue-specific functions (Montonen et al., 2001) . Isoforms 1-4 use different ATG start sites that produce proteins that differ by the length of aminoterminal domain. Recently, it has been shown that different p120 isoforms may have distinct biological functions in normal and malignant epithelial cells (Aho et al., 2002) . Moreover, p120 activity is also dependent on its phosphorylation status (Mariner et al., 2001) . It has been suggested that constitutive tyrosine phosphorylation of p120 by Src contributes to defects in cadherinmediated adhesion in Src-transformed cells (Ozawa and Ohkubo, 2001) , but the exact impact of Src activation in cell adhesion is not well understood. In addition, p120 has also been demonstrated to regulate the actin cytoskeleton and to enhance cell motility indirectly through Rho GTPases Anastasiadis and Reynolds, 2001 ). Similar to other catenins, p120 can also translocate into the cell nucleus (Van Hengel et al., 1999) where it binds to Kaiso, a novel transcription factor of the POZ/ZF family (Daniel and Reynolds, 1999) . Since all these findings point to a role of p120 in modulating cell adhesion and invasiveness, several studies have attempted to assess the potential role of p120 in tumor progression. Abnormalities in p120 expression have now been reported in a variety of tumors (reviewed in Thoreson and Reynolds, 2002) . Reduced or complete loss of p120 expression has been associated with higher stage or poor prognosis in colon, bladder, and prostate cancer, among others .
The purpose of this study was to determine the expression pattern of p120 in the two most frequent histological types of breast cancer, ductal and lobular carcinomas, and its preinvasive lesions, such as atypical lobular hyperplasia. On the assumption that lobular carcinomas almost always lack E-CD protein but ductal tumors do not, our study would serve to evaluate the expression pattern of p120 in the presence or absence of E-CD. In addition, we evaluated whether p120 and E-CD expression was associated with Src kinase activity in ductal breast carcinomas.
Results
Cytoplasmic expression of p120 and complete loss of E-cadherin characterize lobular neoplasia
In contrast to normal ducts, in which E-CD and p120 were markedly expressed in the membrane of epithelial cells, we observed that in all stages of lobular neoplasia, from ALH to metastasis, cytoplasmic localization of p120 and complete loss of E-CD were very common alterations. The preinvasive lobular lesions ALH and LCIS showed complete loss of E-CD expression in 27/29 (93%) and 7/9 (77%) of cases, respectively (Figure 1a, c and d) . Interestingly, p120 showed a diffuse cytoplasmic localization in 26/29 (90%) of ALHs (Figure 1b and c) and 9/9 (100%) of LCIS (Figure 1d ), although focal membranous p120 expression was also seen in some cells. Moreover, in the majority of ILC tumors, E-CD was absent (Table 1, Figure 1e ) and p120 was exclusively localized in the cytoplasm (Figure 1f and g ). We also noted that 64% of ILCs had a high level of immunohistochemical staining of p120 in the cytoplasm, suggesting that p120 is accumulated (Figure 1g ), whereas 24% of ILCs showed weak to normal levels of p120 staining in the cytoplasm (Table 1) . Four cases with cytoplasmic accumulation also demonstrated nuclear p120 staining in about 10-15% of neoplastic cells (Figure 1j ). Interestingly, cytoplasmic localization of p120 was clearly associated with the absence of E-CD expression in ILCs (contingency test, P ¼ 0.001), since no p120 cytoplasmic or nuclear expression was found when E-CD was retained in the membrane. Moreover, the combined phenotype of complete loss of E-CD and cytoplasmic accumulation of p120 was also found in the associated in situ component in 67% of ILCs (Figure 1e and f). Additionally, in 9/13 (70%) metastatic lymph nodes, loss of E-CD and cytoplasmic accumulation and focal nuclear p120 staining were observed (Figure 1h ). We then investigated whether E-CD loss was also associated with cytoplasmic localization of b-catenin in lobular lesions. However, b-catenin was severely reduced or absent in almost all ALHs (26/29, 90%), LCISs (7/9, 78%) and infiltrating lobular tumors (Table 1, Figure 1i ). Moreover, we investigated whether preinvasive lobular lesions adjacent to invasive ductal carcinoma (IDC) tumors showed the same staining patterns as that observed in invasive tumor cells. Well-defined precursor lesions for ductal carcinoma such as atypical ductal hyperplasia (n ¼ 6) demonstrated normal membranous expression of E-CD and p120 (not shown). By contrast, ALH lesions adjacent to ductal tumors (n ¼ 5) showed diffuse cytoplasmic localization of p120, and loss of E-CD protein, thus suggesting that these expression patterns in ALH arose whether or not these lesions were associated with invasive ductal tumor. Apart from this, since almost all ALHs lacked E-CD expression, we investigated whether LOH at CDH1 locus occurred in these lesions and found that two of the five (40%) informative cases demonstrated LOH (not shown).
Reduced membranous p120 frequently occurs in ductal tumors
To establish whether altered expression of p120 was specific to the lobular histotype, 219 invasive ductal tumors were analysed. The results are summarized in Table 1 . In these tumors, p120 was almost always (88%) localized in the membrane (Figure 1k and l) and rarely appeared in the cell cytoplasm. High levels of cytoplasmic p120 were only observed in three cases (1.5%), which also lacked E-CD staining. Reduction of p120 in p120 expression in breast cancer D Sarrió et al the membrane was the most common expression pattern in ductal tumors (Figure 1l ). Thus, p120 localization and expression differed significantly between ductal and lobular carcinomas (Po0.001, Table 1 ). Moreover, membranous reduction of E-CD and b-catenin was very frequent in IDCs, but complete loss of these proteins was rare. Additionally, four IDCs completely lacked p120 expression. It is worth noting that in IDC p120 and E-CD expression and Src kinase activity in ductal breast carcinomas
Since tyrosine phosphorylation by c-Src contributes to defects in the E-CD-catenin adhesion complex (Daniel and Reynolds, 1997) and we have observed that about 50% of IDCs had reduced E-CD and p120 expression, we tested whether the levels of expression of these proteins were related to c-Src kinase activity in 46 frozen IDC tumors. The mean value of Src activation was higher in tumors with preserved E-CD (2.43 þ 2.0 s.d., arbitrary units (AU)) than in those with reduced E-CD (1.5 þ 1.2 AU). Tumors with preserved p120 expression showed higher Src activity (2.37 þ 2.1 AU) than those with reduced p120 (1.47 þ 1.0 AU). However, the differences between groups were not statistically significant (t-test, P ¼ 0.068 for E-CD, and P ¼ 011 for p120). Src activity was also studied in four lobular tumors, but no differences between these tumors were found (not shown).
Primary cell cultures from lobular breast carcinomas lack E-CD protein and show cytoplasmic and nuclear localization of p120
We next studied whether cytoplasmic localization of p120 also occurred in lobular cancer cells in vitro. To this end, we generated five primary cell cultures from ILC tumors. To ensure the epithelial origin of the cultures, we stained for the presence of cytokeratins since they are specific epithelial makers. All of these primary cultures showed positive cytokeratin staining in the cytoplasm (Figure 2a ). However, most of the cells showed a disorganized cytokeratin matrix or even a residual punctuate staining (not shown). We next compared E-CD and p120 expression in these cells with those observed in established ductal carcinoma cell lines. As reported elsewhere, MCF7 and T47D cell lines expressed high levels of membranous E-CD and p120, whereas cytoplasmic p120 staining was not observed. By contrast, all the primary lobular cancer cultures generated by us were completely negative for E-CD expression by RT-PCR, Western blot ( Figure 4 ), and immunofluorescence experiments, but p120 was diffusely localized in the cytoplasm of the cells, and occasionally in the nuclei (Figure 2b -d). Membranebound p120 was very focal and scarce. To ensure that p120 was localized in the nucleus of lobular tumors, these primary cell cultures were treated with leptomycin-B, a specific nuclear protein export inhibitor that has previously been demonstrated to retain endogenous p120 in the nucleus (Van Hengel et al., 1999) . After treatment, nuclear p120 expression was evident in all primary lobular cancer cultures by immunofluorescence (Figure 2d ), whereas the treatment has no detectable effect on p120 localization in T47D or MCF7 cells (not shown).
p120 cytoplasmic localization is a consequence of the absence of a functional E-CD
We next tried to demonstrate that p120 cytoplasmic localization in breast cancer cells was a consequence of complete E-CD loss. To this end, we used the MDA-231 breast cancer cell line, which has a fibroblastic phenotype, completely lacks E-CD expression, and has high levels of cytoplasmic p120 ( Figure 3a ). Since the absence of E-CD protein in this cell line is caused by transcriptional silencing of CDH1 gene due to the extensive hypermethylation of CDH1 promoter (Graff et al., 1995) , we treated MDA-231 cells with the demethylating agent 5-Aza-2 0 -deoxycytidine (5Aza) Figure 3a) . Interestingly, in E-CD-expressing cells, p120 shifted from the cytoplasm to the membrane, where it colocalized with the endogenous reexpressed E-CD (Figure 3a) , whereas in E-CD-negative cells, p120 remained in the cytoplasm. 5Aza treatment did not affect E-CD or p120 expression in T47D ( Figure 3a ) and MCF7 cells (not shown).
To further demonstrate that loss of E-CD produces cytoplasmic localization of p120, we took advantage of a previously described model for efficiently suppressing E-CD expression in epithelial cells. The Madin-Darby canine kidney (MDCK) cell line, which expresses high levels of membranous E-CD, was stably transfected with constructs encoding Snail, E47, or Slug proteins, three potent transcriptional repressors of E-CD (Cano et al., 2000; Perez-Moreno et al., 2001; Bolos et al., 2003) . MDCK control cells (MDCK-CMV, transfected with an empty vector) have an epithelial phenotype, and express E-CD and p120 in membrane, where they colocalize (Figure 3b ). By contrast, Snail-, Slug-, and E47-transfected MDCK cells, which undergo an epithelial to mesenchymal transition, completely lacked E-CD expression (Figure 3b and 4a) , and showed an apparent localization of p120 in the cytoplasm (Figure 3b ; MDCK-Slug not shown). Hence, in the absence of E-CD, p120 shifted from the membrane to the cytoplasm in MDCK cells.
p120 isoforms in primary lobular breast cancer cultures and cell lines
Since most of the lobular tumors lacking E-CD showed high levels of cytoplasmic p120 staining, implying that p120 may be upregulated, we then investigated whether our primary lobular cultures had greater total amounts of p120 protein or mRNA than did other breast cancer cell lines. RT-PCR and Western blot revealed no clear quantitative differences between the cell lines studied (Figure 4a and b) , but we observed that all the primary lobular cultures expressed the same p120 isoforms. By Western blot, using the pan-p120-specific antibody pp120, two major bands migrating at around 120 kDa (corresponding to isoform 1) and 100 kDa (isoform 3) were detected in all the primary cultures. A faster migrating band at around 65 kDa, which may correspond to isoform 4, was also observed (Figure 4a ). Interestingly, this pattern of p120 isoforms was very similar to that observed in the E-CD-negative cell lines MDA-231 and MDA-435. By contrast, the E-CDpositive cell lines MCF7 and T47D did not express isoform 1. In these cell lines, isoform 3 was predominantly detected, although a slower migrating band corresponding to either isoform 2 or phosphorylated isoform 3 was also observed. To ensure the specificity of the bands detected, the experiments were repeated using different protein extraction methods and buffers. The repeated experiments yielded the same results (not shown). Moreover, two additional experimental approaches were used to confirm these results. First, we used the 6H11 mAb (which specifically recognizes the longest p120 isoforms 1 and 2) in the Western blot analysis and observed that it detected a single band of around 120 kDa (isoform 1). Second, we analysed the expression of the mRNA isoforms by RT-PCR, using a primer set that amplifies the 5 0 region of p120 mRNA. The most abundant mRNA transcripts in our primary cultures and in the E-CD-negative cell lines were of types 1 and 3, whereas in E-CD-positive cell lines no expression of the type 1 isoforms was observed Figure 4b) . A panel of non-breast cancer cell lines (HaCaT, HeLa, and HUVEC), whose p120 isoform patterns have been previously established, were used as control for p120 isoform profiles. As reported before, HeLa and HUVEC cells express easily detectable levels of p120 isoform 1, whereas HaCaT cells do not (Mo and Reynolds, 1996; Aho et al., 2002) .
A similar upregulation of isoform 1 was observed by Western blot in MDCK-Snail, MDCK-Slug, and MDCK-E47 cells in comparison to MDCK control cells (Figure 4a ). Although the total amount of p120 is similar in MDCK transfectants and control cells, transfection of Snail, Slug, or E47 induced a large increase in the levels of isoform 1, which is normally an isoform of minor importance in this cell type. Again, this result was confirmed with the 6H11 mAb. Finally, MDA-435 and 231 cell lines, which lack E-CD and express high levels of the p120 isoform 1, are also known to express nonepithelial cadherins, such as cadherin-11 and N-cadherin (N-CD). We then analysed our primary cultures and cell lines for the presence of N-CD and detected its expression in three out of five primary cultures, and also in MDA-435, HeLa, HaCaT, and HUVEC cell lines. N-CD expression associates with the presence of isoform 1, except in HaCat cells, which also express E-CD (Figure 4a ).
Discussion
Accumulating evidence indicates that alterations in the E-CD-catenin complex play an important role in tumor behavior and progression (Beavon, 2000) . Altered expression of E-CD has been widely observed in a variety of tumor types, whereas p120 expression is currently being investigated in human cancer. To date, decreased p120 expression with respect to its normal epithelial tissue has been reported in a variety of human carcinomas, and reduced p120 expression correlated with disease progression in some instances, thus suggesting a tumor suppression role for p120 . Here, we compared for the first time p120 expression in the two major types of invasive Figure 4 mRNA and protein expression of cadherins and p120 in LOBs and cancer cell lines. (a) Differential E-CD, N-CD, and p120 expression among the cell lines by Western blot. Several bands are detected using a p120 C-terminus specific mAb. The p120 isoforms were identified by their differential molecular weights as indicated. 6H11 mAb was used to recognize p120 isoform 1. As a loading control, a-tubulin (a-tub) was used. (b) E-CD and p120 expression by RT-PCR. Total E-CD and p120 mRNA levels are depicted in the upper panels. Middle panel: identification of the different p120 transcripts expressed in the cell lines used. Numeric isoform codes are indicated on the right, and their band sizes on the left. b2-Microglobulin (b2microg) expression was used as internal control p120 expression in breast cancer D Sarrió et al breast cancer (ductal and lobular) and found that it significantly differed between them. In ILCs, normal membranous p120 expression is very rare, since most (88%) of the analysed ILCs showed cytoplasmic mislocalization. Moreover, in most cases, a strong cytoplasmic staining of p120 was observed, which may indicate that p120 is accumulated in the cell cytoplasm. Cytoplasmic localization of p120 was also observed in the majority of atypical lobular hyperplasias, and LCISs (two lobular lesions likely to be precursors of ILC), and also in metastatic lesion from ILCs. Therefore, this implies that p120 cytoplasmic mislocalization appears in the early stages of lobular tumorigenesis and is maintained during lobular cancer progression. By contrast, in our series of ductal tumors, p120 was frequently reduced in the membrane, and 2% of the cases completely lacked p120 staining. Cytoplasmic localization, however, was rarely observed in the present series, coinciding with the findings of two previous studies in ductal tumors (Dillon et al., 1998; Nakapoulou et al., 2002) . These data indicate that p120 is frequently reduced in ductal breast carcinomas, and that a proportion (from 2 to 10%) of ductal tumors completely lack p120 expression. Taking into account the close functional relationship between p120 and other components of the E-CD-catenin complex, we examined whether altered p120 expression was associated with abnormal E-CD or b-catenin expression in our tumor series. We found that p120 expression was strongly associated with E-CD and b-catenin expression in both lobular and ductal tumor types, but in very distinct manners. Whereas a high proportion of lobular carcinomas with p120 cytoplasmic localization showed complete loss of E-CD and b-catenin expression, E-CD and b-catenin reduction in ductal tumors was significantly associated with reduced levels of membranous p120, but not with its cytoplasmic localization. Simultaneous loss of E-CD, a-, and b-catenin expression is widely observed in lobular tumors, whereas the concurrent reduction of membranous E-CD, a-, and b-catenin levels is also a common finding in ductal tumors (Jiang and Mansel, 2000) . However, although Dillon et al. found no correlation between p120 expression and that of other components of the cadherin complex, our data and the findings of a recent report (Nakapoulou et al., 2002) strongly suggest that p120 reduction is also associated with a reduction in membranous E-CD and other catenins in ductal tumors. This simultaneous reduction in various members of the adhesion complex may be linked to phosphorylation events. Indeed, tyrosine phosphorylation by Src tyrosine kinase of members of the cadherin-catenin complex, including p120, has been reported to disrupt the adherent junctions (Daniel and Reynolds, 1997) . Thus, we investigated whether E-CD and p120 levels were associated with Src kinase activity in ductal tumors. Although we have not evaluated the phosphorylation status of p120, we found that the mean value of Src activity was higher in IDC with preserved p120 or E-CD expression than in those with reduced p120 or E-CD expression, thus implying that increased Src activity is not associated with a reduction in E-CD or p120. Our results are in accordance with previous experimental evidence that indicates that Src-induced p120 tyrosine phosphorylation increased its affinity for E-CD (Roura et al., 1999) . As mentioned above, lobular tumors lack E-CD and b-catenin expression but accumulate p120 in the cytoplasm. Similarly, cytoplasmic p120 localization has been reported in a subset of pancreatic cancers (Mayerle et al., 2003) and in a high proportion of diffuse gastric cancers (Jawhari et al., 1999) , a tumor known frequently to harbor CDH1 mutations (Berx et al., 1998) . Interestingly, we observed here that cytoplasmic localization of p120 was closely associated with loss of E-CD at all stages of lobular tumorigenesis, from ALH to metastasis. Moreover, in a panel of primary lobular cancer cultures generated by us, E-CD protein was not detectable in any case, but p120 was almost exclusively localized in the cell cytoplasm. Therefore, it is reasonable to conclude that p120 cytoplasmic accumulation in lobular carcinoma and other tumor types is the result of complete E-CD inactivation. These findings are in accordance with in vitro observations, indicating that in the absence of a functional E-CD, unlike the other catenins, p120 is metabolically stable and accumulates in the cytoplasm (Thoreson et al., 2000) . Here, we demonstrate a direct link between the absence of E-CD and p120 cytoplasmic mislocalization in breast cancer cells. After re-expression of endogenous E-CD in MDA-231 cells by 5Aza treatment, an epithelial phenotype was restored, and p120 was recruited from the cytoplasm to the membrane, where it colocalized with endogenous E-CD. Our experiment confirms previous in vitro studies showing the same effect of the stable transfection of ectopic E-CD in E-CD-negative cell lines (Thoreson et al., 2000) . Moreover, in a reverse experiment, we demonstrated that suppressing E-CD expression in MDCK cells by stable transfection of the transcriptional repressors Snail, E47, or Slug, provokes a p120 shift from the membrane to the cell cytoplasm, thus implying that in epithelial cells the absence of E-CD is followed by cytoplasmic mislocalization of p120.
Does cytoplasmic p120 accumulation have any biological relevance in lobular breast cancer? Overexpression of transfected p120 in fibroblast and epithelial cell lines produces a dendritic phenotype characterized by long branched processes, loss of stress fibers, reduction of focal adhesions, and cytoskeleton remodeling, which is mediated by Rho family of GTPases Anastasiadis and Reynolds, 2001) . As a consequence of these alterations, cells with p120 overexpression show increased motility, implying that p120 may play a role as a metastasis promoter ). Accordingly, mRNA upregulation, cytoplasmic distribution, and nuclear import of p120 have recently been demonstrated to be associated with a more malignant and invasive phenotype in pancreatic cancer (Mayerle et al., 2003) . However, although 64% of our ILC tumors p120 expression in breast cancer D Sarrió et al showed high levels of p120 staining in the cytoplasm, suggesting that p120 may be upregulated, it was unfortunate that we could not measure the levels of p120 mRNA in our tumors, since no RNA samples were available. Nonetheless, we compared the mRNA and protein levels of p120 in our primary lobular cultures with those in established breast cancer cell lines. Although we did not find clear differences in the quantity of mRNA or protein, we observed that the largest p120 isoform (isoform 1) was highly expressed in our primary lobular cultures, and the E-CD-negative cell lines, but not in the E-CD-positive cell lines analysed. A similar isoform 1 upregulation was observed in MDCK cells after transfection with E47, Snail, or Slug, three potent transcriptional repressors of E-CD gene. Moreover, it has been widely reported that cadherin switching plays a role in cancer progression. Specifically, loss of E-CD and upregulation of the mesenchymal N-CD and cadherin-11 occurs in a variety of carcinoma cells (Tomita et al., 2000) . Here, we confirm previously reported data indicating that some E-CD-negative tumors and cell lines express N-CD (as occur in our primary lobular cultures), and that N-CD expression may also be associated with an increase in p120 isoform 1 (Husmark et al., 1999; Tran et al., 1999) . Since isoform 1 is characteristic of fibroblast and highly motile cells (Mo and Reynolds, 1996) , our data support the notion that cells with a fibroblastic phenotype, lacking E-CD, and/or expressing N-CD may express a set of p120 isoforms that could play a role in the acquisition of a more invasive behavior. In fact, upregulation or loss of specific p120 isoforms has shown to contribute to a more invasive phenotype in tumor or normal cells (Aho et al., 2002) . Whether lobular breast carcinomas express mesenchymal cadherins is currently being investigated.
Furthermore, several E-CD-negative breast cancer cell lines show endogenous p120 in the nucleus (Van Hengel et al., 1999; Thoreson et al., 2000) and the induction of the dendritic phenotype seems to be associated with nuclear localization of some p120 isoforms (Aho et al., 2002) . We observed that p120 nuclear localization also occurred in lobular carcinoma. However, although the majority of lobular tumors accumulated cytoplasmic p120, only 4/67 (6%) had prominent nuclear expression. This observation can be explained by the fact that a putative nuclear export signal with a characteristic leucine-rich motif is encoded by p120 exon B (Van Hengel et al., 1999) , which thus avoids p120 accumulation in the nucleus. In fact, after blocking the nuclear export of p120 by leptomycin-B treatment, nuclear localization of p120 was evident in our primary lobular tumor cultures. A nuclear binding partner of p120 is the recently identified transcription factor Kaiso (Daniel and Reynolds, 1999) , which behaves as a methylation-dependent transcriptional repressor and is one of the two methyl-CpG binding complexes originally designated as MeCp1 (Prokhortchouc et al., 2001) . Thus, p120 may link events at the cell surface with DNA methylation-dependent gene silencing.
Very recently, in vitro experiments have suggested a tumor suppressor role for p120: SW48 colon cancer cells, which are deficient in membranous p120 levels, harbor an inactivating mutation in p120 gene (CTNND1) (Ireton et al., 2002) . This deficiency in SW48 cells results in strongly reduced levels of E-CD, which in turn lead to weakened intercellular adhesion. Restoring p120 rescues the epithelial phenotype and stabilizes E-CD to normal levels in cell-cell contacts, thereby implying that loss of p120 might be responsible for E-CD downregulation in some instances.
Taken together, our data from breast cancer provide in vivo evidence that support a recently proposed model of a dual role for p120 as a tumor suppressor and metastasis promoter . This model suggests that the function may depend on the order in which p120 or E-CD is downregulated. Thus, if p120 is lost first (as, perhaps, in ductal breast tumors), E-CD levels will fall significantly, whereas if E-CD is lost first (as in lobular breast cancer), p120 may accumulate in the cytoplasm and enter the nucleus. At both cellular locations, p120 may play additional roles, such as regulation of transcriptional events or modulation of the motility behavior, which, as a result, promotes metastasis. Consistent with this, it is widely acknowledged that inactivation of E-CD gene is an early event in lobular tumorigenesis, since genetic alterations in CDH1 occur in LCIS (Sarrio´et al., 2003) and, as we demonstrate here, in ALH. However, whether p120 loss in ductal tumors is due to genetic or epigenetic inactivation of CTNND1 gene remains to be demonstrated.
Finally, from a diagnostic point of view, our study demonstrates that most ALH lesions show an abnormal pattern of expression of the E-CD-catenin molecules resembling that found in LCIS and ILC tumors (absence of E-CD, and b-catenin staining and p120 cytoplasmic localization). Although some investigators consider ALH as a 'risk indicator' for the development of invasive cancer rather than true precursor lesions (Lishman and Lakhani, 1999) , recent evidence has demonstrated that the genetic profiles of ALH and LCIS are similar to each other and to those of ILC (Lu et al., 1998) . Interestingly, although a larger series of ALHs needs to be studied to confirm these preliminary results, we found that the early complete loss of E-CD expression in ALH may be a consequence of genetic alterations affecting CDH1 locus, such as LOH. Since LOH at CDH1 locus is a very common finding in ILCs, and bearing in mind our immunohistochemical results, our data point to a common origin for the ALH, LCIS, and ILC entities, and indicate that both ALH and LCIS are precursor lesions for ILC. The fact that ALH has a completely different pattern of E-CD and catenin immunostaining to ADH and ductal carcinomas occurring in the same breast raises the question of whether these ductal tumors arose from similar lobular lesions or from independent lesions of a distinct nature.
In summary, altered expression of p120 may have different causes and consequences in ductal and lobular tumors. Cytoplasmic p120 localization, which occurs p120 expression in breast cancer D Sarrió et al in the early stages of lobular neoplasia, and is maintained during lobular tumor progression to metastasis, may play an important role in mediating the oncogenic effects derived from E-CD inactivation, including enhanced motility and invasion. Representative areas from the infiltrating carcinomas were carefully selected on H&E-stained sections, and two tissue cores (1 mm in diameter) were obtained from each specimen. The tissue cores were precisely arrayed into a new paraffin block using a tissue microarray workstation (Beecher Instruments, Silver Spring, MD, USA).
Materials and methods

Tissue samples and tissue microarray construction
Immunohistochemistry
Immunohistochemical staining was performed by the LSAB (Dako, Glostrup, Denmark) method with a heat-induced antigen retrieval step, as previously described. Mouse antihuman E-CD (4A2C7, Zymed, San Francisco, CA), anti-bcatenin, and anti-p120 (both from Transduction Labs, Lexington, KY) monoclonal antibodies were applied at dilutions of 1 : 200, 1 : 1000, and 1 : 500, respectively. All studied TMAs also included normal breast tissue as an internal control. In negative controls, the primary antibodies were omitted. Three pathologists (JP, BPM, and DH) simultaneously evaluated the immunohistochemistry, and immunoreactivity was scored as absent (no staining), reduced or weak (intensity weaker to that observed in normal ducts), normal (same intensity), and strong (at least twice the intensity of normal cells). Localization was scored as membranous or cytoplasmic depending on the predominant expression pattern.
Laser capture microdissection, DNA extraction, and assessment of loss of heterozygosity at CDH1 locus Epithelial cells from the selected ALH lesions (n ¼ 7) and normal ducts were extracted by a membrane-based laser capture microdissection (LCM) technique, performed essentially as described before (Moreno-Bueno et al., 2002) . The experimental conditions and the method used for LOH calculation have been previously reported (Sarrio´et al., 2003) .
Immunoprecipitation of c-Src and in vitro kinase assay
Frozen biopsies were powdered in liquid nitrogen and approximately 4 mg of each biopsy was extracted with 1 ml of lysis buffer (10 mM Tris-HCl pH 7.4, 10 mM sodium pyrophosphate pH 7.4, 10 mM NaF, 5 mM EDTA, 130 mM NaCl, 1% Triton X-100, 0.1 mM Na 3 VO 4 , 1mM phenylmethylsulfonyl fluoride, 1 mM phenantroline, 1 mM benzamidine hydrochloride, 1 mM iodoacetamide) for 1 h at 41C in an orbital shaker. Lysates were then clarified by centrifugation at 100 000 g for 30 min at 41C. Immunoprecipitation was performed by incubating the lysate protein with 1 mg of antiSrc 327 mAb (a gift from JS Brugge, Harvard University, Boston) for 2 h at 41C. Immune complexes were then used for in vitro Src kinase assay following the previously described method (Fresno Vara et al., 2000) .
Cell culture, transfection, and treatments MDCK cell lines, human breast cancer cell lines (MCF7, T47D, MDA-231, and MDA-435), and non-breast cancer cell lines (HeLa, HaCaT and HUVEC) were grown in DMEM medium, supplemented with 10% fetal calf serum (FCS), and 1% penicillin-streptomycin (PS). All cells were routinely cultured in 5% CO 2 at 371C. MDCK cells stably transfected with either Snail, E-47, Slug, or the empty vector (MDCK-CMV) have been previously reported (Cano et al., 2000; PerezMoreno et al., 2001; Bolos et al., 2003) . To generate primary cell cultures from lobular breast carcinomas, a piece of fresh tumor tissue was obtained from the hospitals involved in the study (see Acknowledgements) on the day of surgery. The tissue was immediately cut into small pieces using sterile surgical blades, and then digested with collagenase for 1-2 h at 371C. Released tumoral cells were washed with PBS buffer and then plated into F25 culture flasks containing Ham-F10 medium supplemented with 20% FCS, 1% PS, and 1% Ultroser G. All media and reagents were purchased from Invitrogen Ltd, Paisley, UK. All primary cultures were grown in the presence of cholera toxin (Sigma Chemicals, St Louis, MO, USA) to inhibit fibroblast growth, and stayed viable at least until passage 10. For demethylation experiments, cell lines were grown in the appropriate media in the presence of the demethylating agent 5Aza (from Sigma) at a concentration of 5 mM for 4 days. To inhibit nuclear export of p120, cells were treated with leptomycin-B (Sigma) at a concentration of 5 ng/ ml for 18 h.
Immunofluorescence and Western blotting
For immunofluorescence experiments, cultured cells were fixed in 100% methanol at À201C for 5 min. The primary antibodies used were rat anti-E-CD (DECMA-1 from Sigma), anti-p120 (dilution 1 : 250), and anticytokeratins (AE1/AE3 from Biomeda, dilution 1 : 500). Secondary antibodies were Alexa594-coupled anti-mouse Ig, and FITC-coupled anti-rat Ig (Molecular Probes, Eugene, OR, USA). Cells were counterstained using 4,6-diaminidino-2-phenylindole (DAPI) (Molecular Probes). For Western blotting, cells were lysed on the culture dishes, and proteins were extracted using standard RIPA buffer. Protein concentration was determined by BCA protein assay (Pierce, Rockford, IL, USA), and equal amounts were loaded in 6% SDS-PAGE gels. Polypeptides were transferred onto Immobilon-P (Millipore, Bedford, MA, USA) nitrocellulose membranes, and nonspecific binding was blocked with 5% nonfat dry milk. Each blot was independently incubated with each of the following monoclonal antibodies: anti-p120 (1 : 1000 dilution), anti-E-CD (1 : 1000), anti-N-CD (3B9, Zymed, 1 : 500), or 6H11 monoclonal antibody (a generous gift from Al Reynolds; Vanderbilt University, Nashville, TN, USA). 6H11 antibody specifically recognizes the longest p120 isoforms, and was used at 1 mg/ml. Anti-a-tubulin (Sigma, p120 expression in breast cancer D Sarrió et al 1 : 10 000) was used in all the blots as a loading control. Antimouse Ig HRP-conjugated secondary antibody (Amersham, Buckinghamshire, UK, 1 : 1000 dilution) was used and visualized with the ECL chemiluminescence detection kit (Amersham). In some cases, the membranes were stripped using the adequate buffer (10 mM Tris pH 6.8, 2% SDS, 0.1 M 2-mercaptoethanol) for 15 min at 651C, and reprobed with other primary antibodies.
RT-PCR analysis
Total RNA was isolated from the different cell lines using RNeasy Mini Kit (Qiagen, Hilden, Germany) following the manufacturer's instructions. cDNA was synthesized using RT-PCR AMV Kit (Promega Co., Madison, WI, USA) and was subsequently used for PCR amplification of E-CD (using primers and conditions as reported in Kohy et al., 2002) , and p120 (primers Ex10F2 and Ex12R1 as reported in Keiserbilck et al., 1998) . To estimate the levels of p120 mRNA, a semiquantitative RT-PCR was performed using b2-microglobulin (predeveloped Kit assay, PE Biosystems, Warrington, UK) as an internal control. Abundance of p120 mRNA relative to control mRNA was measured using Quantity One Software 4.1 (BioRad, Hercules, CA, USA). To analyse the p120 mRNA isoform profile, we amplify the 5 0 region of p120 mRNA using the Ex1F6 and Ex5R1 primers as previously reported (Keiserbilck et al., 1998) . All the amplified bands were excised from the gel, purified using Gel Extraction Kit (Qiagen) and sequenced to identify the p120 mRNA transcripts.
Statistical analysis
The contingency test with Yates correction or Fisher's exact test, and Student's t-test were performed where appropriate to determine the statistical significance of the relationships between the variables analysed. The SPSS 10.1 software package for Windows (SPSS, Inc., Chicago, IL, USA) was used.
